急诊静脉溶栓治疗急性心肌梗塞疗效分析

Analysis of the Clinical Effect of Thrombolysis Therapies in Patients with Acute Myocardial Infarction on Emergency

目的 探讨急诊静脉溶栓治疗急性心肌梗塞的疗效。方法 6 8例急性心肌梗塞患者分别予以尿激酶 (UK)、链激酶(SK)和重组组织型纤溶酶原激活剂 (rt PA)溶栓治疗 ,根据冠脉再通率和病死率分析静脉溶栓治疗急性心肌梗塞的疗效。结果 溶栓治疗后冠脉再通率、心功能明显改善 ;无一例死于溶栓后出血。结论 急诊静脉溶栓治疗急性心肌梗塞疗效好、安全、可行。

Objective To analyze the clinical effect of thrombolysis therapies on acute myocardial infarction.Methods 68 patients with acute myocardial infarction were treated with Urokmase(UK)、Streptokinase(SK) and recombinant tissue plasmin activator(rt PA),respectively.We analysed the clinical effect of thrombolysis therapies on acute myocardial infarction according to the reperfusion rate of coronary and the fatality rate. Results The reperfusion rate of coronary and the cardiac function was significantly improved after thrombolysis treatment;furthermore,no one died for haemorrhagia after thrombolysis treatment.Conclusion Thmmbolysis therapy on acute myocardial infarction on emergency is safe and feasible and can achieve good clinical effect.